NasdaqGM:SIONBiotechs
Assessing Sionna Therapeutics (SION) Valuation After Strong Recent Share Price Momentum
Recent performance snapshot
Sionna Therapeutics (SION) has quietly drawn more investor attention after a series of completed clinical trials across its cystic fibrosis pipeline, with the stock posting gains over the past month and over the past three months.
See our latest analysis for Sionna Therapeutics.
With the share price at $42.82, Sionna Therapeutics has paired a 9.37% 30 day share price return and 25.61% 90 day share price return with a very large 1 year total shareholder return of...